| OHSU # 1978 |
C57BL6-Pahenu2 mouse |
Cary Harding |
| OHSU # 1455 |
Mouse lines for the conditional elimination of the expression of the peripheral benzodiazapine receptor |
Michael Forte, Elizabeth Blachly-Dyson, Paolo Bernardi |
| OHSU # 1420 |
Snm1 Mutant Mouse Strain |
Robb Moses |
| OHSU # 1402 |
Flagmor transgenic mouse |
John Williams |
| OHSU # 1224 |
Murine Model System for Human Cytomegalovirus Latency and Pathogenesis |
Jay Nelson, J. Victor Garcia-Martinez, William Fleming, Florence Othieno, Alexis Bailey, Felicia Goodrum |
| OHSU # 1187 |
SK3 Floxed Allele Mice (SK3 Null Mice) |
John Adelman, Chris Bond, James Maylie |
| OHSU # 1112 |
Transgenic Mice C57BL/6J-Tg(Pomc-EGFP)1Low/J |
Malcolm Low, Veronica Otero-Corchon, Marcelo Rubinstein |
| OHSU # 0959 |
CyP-D Knock-Out Mice |
Michael Forte, Paolo Bernardi, Emy Basso |
| OHSU # 0891 B |
Small-Conductance CA2+-Activated Potassium Channel 2 (SK2) Transgenic Mice |
John Adelman, Chris Bond, James Maylie |
| OHSU # 0891 |
Small-Conductance CA2+-Activated Potassium Channel 1 (SK1) Transgenic Mice |
John Adelman, Chris Bond, James Maylie |
| OHSU # 0640 |
POMC transgenic mice and neuron-specific promoter |
Malcolm Low, Marcelo Rubinstein, Flavio Silva de Souza |
| OHSU # 0515 |
Small-Conductance Ca2+-Activated Potassium Channel 3 (SK3) transgenic mice |
Chris Bond, John Adelman |
| OHSU # 0502 |
Melanocortin-3 Receptor Knockout Mice |
Roger Cone, Andrew Butler, Robert Kesterson |
| OHSU # 0417 |
Pms-2 Knockout Mouse |
Robert Liskay, C. Eric Bronner, Sean Baker, Richard Flavell |
| OHSU # 0405 |
D2 Dopamine Receptor Knock-Out Mice |
Malcolm Low, David Grandy, Marcelo Rubinstein, Michele Kelly |
| OHSU # 0387-B |
MC5-R Knockout mice |
Malcolm Low, Wenbiao Chen, Roger Cone |
| OHSU # 0379 |
D4 Dopamine Receptor Knock-Out Mice |
Malcolm Low, David Grandy, Marcelo Rubinstein |